Francesco Antonio Veneziano: JCDD MDPI Calls for Papers on Advances in Thrombosis and Antithrombotic Therapy
Francesco Antonio Veneziano, Cardiologist at ULSS 8 Berica Local Health Authority, shared on LinkedIn:
”CALL FOR PAPERS – Advances in Thrombosis and Antithrombotic Therapy (JCDD MDPI)
Managing thrombosis in daily clinical practice is becoming increasingly complex.
From acute coronary syndromes to high-risk patients with multiple comorbidities, we are constantly balancing ischemic and bleeding risks, often with limited precision.
This Special Issue aims to bring together clinically meaningful and innovative contributions to improve how we:
- Stratify thrombotic risk
- Integrate biomarkers, imaging, and AI
- Tailor antithrombotic therapy in complex settings
We are currently inviting:
- Original research
- Review articles
- Perspectives
Submission deadline: 30 November 2026
If you are working on these topics, feel free to reach out – happy to discuss ideas or potential contributions.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 11:05Julius Kyei Baffour: Understanding Thrombophilia Testing and Patient Risk
-
Apr 15, 2026, 09:10Shall I Bleed Less with Age? Just 2 Weeks Until the Webinar – EHC
-
Apr 15, 2026, 08:51Moustafa Abdou: Sutimlimab is Transforming Outcomes in Cold Agglutinin Disease
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?